BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38473343)

  • 1. Beneficial Effect of Metformin on the Five-Year Survival in about 40,000 Patients with Head and Neck Cancer.
    Gaertner F; Preissner S; Heiland M; Preissner R; Wüster J
    Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin Medication Improves Five-Year Survival Rates in Patients with Head and Neck Cancer: A Retrospective Case-Control Study of about 100,000 Patients.
    Wüster J; Heiland M; Nahles S; Preissner R; Preissner S
    Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of five-year survival rates among patients with oral squamous cell carcinoma with and without association with syphilis: a retrospective case-control study.
    Hertel M; Hagedorn L; Schmidt-Westhausen AM; Dommisch H; Heiland M; Preissner R; Preissner S
    BMC Cancer; 2022 Apr; 22(1):454. PubMed ID: 35468757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of metformin on disease control and survival in patients with head and neck cancer: a retrospective cohort study.
    Lee DJ; McMullen CP; Foreman A; Huang SH; Lu L; Xu W; de Almeida JR; Liu G; Bratman SV; Goldstein DP
    J Otolaryngol Head Neck Surg; 2019 Jul; 48(1):34. PubMed ID: 31345259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotics Significantly Decrease the Survival of Head and Neck Carcinoma Patients with Immunotherapy: A Real-World Analysis of More Than 3000 Cases.
    Preissner S; Heiland M; Preissner R; Wirth M; Wollenberg B
    Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Association between Metformin and Survival of Head and Neck Cancer: A Systematic Review and Meta-Analysis of 7 Retrospective Cohort Studies.
    Wang Y; Fu T; Liu Y; Yang G; Yu C; Zhang ZJ
    Curr Pharm Des; 2020; 26(26):3161-3170. PubMed ID: 32067604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective case-control study for the comparison of 5-year survival rates: the role of adjuvant and neoadjuvant chemotherapy in craniofacial bone sarcoma in adults.
    Hofmann E; Preissner S; Hertel M; Preissner R; Rendenbach C; Flörcken A; Heiland M
    Ther Adv Med Oncol; 2023; 15():17588359221148023. PubMed ID: 36818689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Herpes simplex infection with significantly increased risk of head and neck cancer: real-world evidence of about 500,000 patients.
    von Stebut J; Heiland M; Preissner R; Rendenbach C; Preissner S
    Int J Dermatol; 2024 Apr; ():. PubMed ID: 38643367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ibuprofen Reduces 5-Year Overall Survival of Head and Neck Cancer Patients With Immunotherapy - A Retrospective Case-controlled Real-World Data Analysis of 10,000 Patients.
    Ebeling M; Derka S; Baudrexl J; Sakkas A; Scheurer M; Wilde F; Schramm A; Pietzka S
    Anticancer Res; 2024 Jan; 44(1):313-322. PubMed ID: 38159991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of metformin on progression of head and neck cancers, occurrence of second primary cancers, and cause-specific survival.
    Kwon M; Roh JL; Song J; Lee SW; Kim SB; Choi SH; Nam SY
    Oncologist; 2015 May; 20(5):546-53. PubMed ID: 25802404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Worse prognosis in females with new onset of depression after oral cancer diagnosis: a retrospective case-control study.
    Hofmann E; Doll C; Rogge A; Preissner R; Heiland M; Preissner S; Koerdt S
    Front Oncol; 2023; 13():1248926. PubMed ID: 37901332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of metformin on the incidence of head and neck cancer in diabetics.
    Yen YC; Lin C; Lin SW; Lin YS; Weng SF
    Head Neck; 2015 Sep; 37(9):1268-73. PubMed ID: 24801563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the Risk of Oral Squamous Cell Carcinoma in Patients with and without Recurrent Aphthous Stomatitis: A Retrospective Evaluation of Real-World Data of about 150,000 Patients.
    Hertel M; Birinci S; Heiland M; Preissner R; Nahles S; Schmidt-Westhausen AM; Preissner S
    Cancers (Basel); 2022 Dec; 14(23):. PubMed ID: 36497491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival impact and toxicity of metformin in head and neck cancer: An analysis of the SEER-Medicare dataset.
    Stokes WA; Eguchi M; Amini A; Hararah MK; Ding D; McDermott JD; Bradley CJ; Karam SD
    Oral Oncol; 2018 Sep; 84():12-19. PubMed ID: 30115470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Relevance of Type 2 Diabetes and Metformin Treatment in Head and Neck Melanoma: Results from a Population-Based Cohort Study.
    Spoerl S; Gerken M; Schimnitz S; Taxis J; Fischer R; Lindner SR; Ettl T; Ludwig N; Spoerl S; Reichert TE; Spanier G
    Curr Oncol; 2022 Dec; 29(12):9660-9670. PubMed ID: 36547172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex-specific Real-World 5-year Overall Survival Rates for (Radio)chemotherapy, Targeted Therapy, and Combinations in Patients With Head and Neck Cancer.
    Baudrexl J; Pietzka S; Scheurer M; Schramm A; Wilde F; Sakkas A; Derka S; Ebeling M
    Anticancer Res; 2024 Jan; 44(1):267-286. PubMed ID: 38159994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of metformin, statins and anti-inflammatory drugs on head and neck cancer: A systematic review.
    Saka Herrán C; Jané-Salas E; Estrugo Devesa A; López-López J
    Oral Oncol; 2018 Oct; 85():68-81. PubMed ID: 30220322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes mellitus, metformin and head and neck cancer.
    Figueiredo RA; Weiderpass E; Tajara EH; Ström P; Carvalho AL; de Carvalho MB; Kanda JL; Moyses RA; Wünsch-Filho V
    Oral Oncol; 2016 Oct; 61():47-54. PubMed ID: 27688104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Five-year Overall Survival Rates Among 18,331 Head and Neck Cancer Patients Exposed to Different Targeted Therapies Through Real-world Data in a Case-controlled Study.
    Baudrexl J; Sakkas A; Pietzka S; Derka S; Vairaktari G; Scheurer M; Schramm A; Wilde F; Ebeling M
    Anticancer Res; 2024 Mar; 44(3):1247-1270. PubMed ID: 38423635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.